Syntiron

Syntiron LLC is a small company based in Saint Paul, Minnesota, with 9 employees. They generate approximately $4 million in annual revenue. Syntiron specializes in developing innovative vaccines for humans. Their technology focuses on identifying microbial antigens, specifically proteins that acquire iron, a crucial nutrient for bacterial survival. These proteins, often found on the surface of bacteria, exhibit similarities across various strains, making them suitable targets for vaccine development. Syntiron's proprietary platform allows for rapid identification of these iron-acquisition proteins. These proteins can then be extracted directly from host cells or produced recombinantly for preclinical vaccine research. Visit Syntiron's website at syntiron.com for more information.